AI is already transforming healthcare delivery for clinicians, patients, and their clinical partnerships, we learn in The Philips Future Health Index 2026. For this year’s annual futures report, Philips conducted…
When Congress enacted the No Surprises Act (NSA), the primary objective was straightforward: protect patients from unexpected out-of-network medical bills. Since implementation in 2022, however, the law has created a…
What You Should Know Digital health orchestration leader Xealth has announced the strategic appointment of Travis Moore as Chief Revenue Officer (CRO). Moore brings over 25 years of healthcare industry…
Right at this moment, a physician is logging out of a new digital health tool for the very last time. Not because it stopped working. But it started feeling like…
Health secretary Robert F. Kennedy Jr.’s new autism panel is championing a controversial communication method popular among parents of severely autistic people. Critics warn of abuse — and fake “telepathy.”
Despite widespread support in polls for legalizing aid in dying, the number of people who go through with the practice remains very small.
KFF Health News' editor-at-large for public health discussed Ebola, GLP-1 drugs, ultraprocessed food, and more in TV appearances this week.
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
Clinical trials have grown more complex than ever before. Protocols are becoming more specialized, endpoints more refined, and eligibility criteria narrower and more precise. At the same time, development programs…
Specialty medications are expanding what is clinically possible, but not without a price. The affordability gap on these therapies continues to widen, placing sustained pressure on health plan budgets. U.S.…